NIH Weekly Funding Opportunities and Policy Notices

Wednesday, January 27, 2021 - 10:12am
Notice NOT-DA-21-013 from the NIH Guide for Grants and Contracts
Wednesday, January 27, 2021 - 9:33am
Notice NOT-AA-21-003 from the NIH Guide for Grants and Contracts
Wednesday, January 27, 2021 - 9:33am
Notice NOT-AA-21-002 from the NIH Guide for Grants and Contracts
Wednesday, January 27, 2021 - 9:33am
Notice NOT-AA-21-001 from the NIH Guide for Grants and Contracts
Wednesday, January 27, 2021 - 1:25am
Notice NOT-OD-21-049 from the NIH Guide for Grants and Contracts
Tuesday, January 26, 2021 - 11:15pm
Notice NOT-CA-21-031 from the NIH Guide for Grants and Contracts
Tuesday, January 26, 2021 - 9:05am
Notice NOT-DE-21-001 from the NIH Guide for Grants and Contracts
Tuesday, January 26, 2021 - 9:03am
Notice NOT-AG-21-015 from the NIH Guide for Grants and Contracts
Tuesday, January 26, 2021 - 8:53am
Notice NOT-DA-21-011 from the NIH Guide for Grants and Contracts
Monday, January 25, 2021 - 11:24pm
Funding Opportunity PAR-20-317 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.
Monday, January 25, 2021 - 8:24am
Notice NOT-RM-21-013 from the NIH Guide for Grants and Contracts
Monday, January 25, 2021 - 7:57am
Notice NOT-DA-21-027 from the NIH Guide for Grants and Contracts
Monday, January 25, 2021 - 2:04am
Funding Opportunity RFA-DA-22-008 from the NIH Guide for Grants and Contracts. To support the development of innovative tools and/or technologies to monitor or manipulate BMCs in vivo and enable investigators to adopt these tools to answer outstanding questions in basic neuroscience. This research will transform our understanding of the mechanistic role of BMCs in human nervous system health and disease and may serve as the foundation for the development of novel BMC-based therapeutics.
Monday, January 25, 2021 - 1:30am
Funding Opportunity PAR-21-106 from the NIH Guide for Grants and Contracts. The objective of the NIA Academic Leadership Career Award (K07) is to provide support for senior investigators who have the expertise and leadership skills to enhance aging and geriatric research capacity within their academic institution.
Monday, January 25, 2021 - 1:05am
Funding Opportunity PAR-21-114 from the NIH Guide for Grants and Contracts. Some projects initiated with SBIR or STTR funding require considerable financing beyond the SBIR/STTR Phase II award to achieve commercialization. The development of medical biotechnology products is often impeded by a significant funding gap (known as the Valley of Death) between the end of the SBIR/STTR Phase II award and the commercialization stage. The goal of this FOA is to assist applicants in pursuing the next appropriate milestone(s) necessary to advance a product/technology that requires Federal regulatory approval or to bring a complex research tool to market. This opportunity aims to facilitate the transition of previously funded SBIR and STTR Phase II projects to the commercialization stage by promoting partnerships between NINDS SBIR or STTR awardees and third-party investors and/or strategic partners in the Phase IIB competing renewal. Applicants are strongly encouraged to secure independent third-party funding throughout the Phase IIB project period.

Pages